TLRY vs TSE · rev $915.5M vs rev $3.51B
Tilray Inc (TLRY) versus Trinseo SA (TSE) — a side-by-side from cached financials, not a winner call.
Tilray Inc (TLRY) is a drug manufacturers - specialty & generic company listed on NASDAQ.
Trinseo SA (TSE) is a specialty chemicals company listed on NYSE.
Latest reported TLRY revenue for 2026-05-31 was $915.5M. Net income was -$121.4M. Revenue was up 11.5% from 2025-05-31 to 2026-05-31. TLRY currently screens at market cap $573.9M.
Latest reported TSE revenue for 2024-12-31 was $3.51B. Net income was -$348.5M. Revenue was down 4.4% from 2023-12-31 to 2024-12-31. TSE currently screens at market cap $8.3M.
TLRY currently screens at market cap $573.9M. TSE currently screens at market cap $8.3M.
Not investment advice. Open the TLRY and TSE stock pages for the full models.
Not investment advice.